Nirsevimab for the prevention of RSV in all infants

Felter, C.

i

Nirsevimab for the prevention of RSV in all infants

Public Domain

October 20, 2022
By Felter, C.
Series: ACIP: Respiratory Syncytial Virus (RSV)

File Language:

English

Details

Personal Author:

Felter, C.
Corporate Authors:

AstraZeneca (Firm) ; Sanofi (Firm)
Description:

\02-RSV-Mat-Ped-Felter-508.pdf
Subjects:

Infant, Newborn Pregnancy Pregnant Women Respiratory Syncytial Virus Infections/prevention & Control Respiratory Syncytial Virus Vaccines
Series:

ACIP: Respiratory Syncytial Virus (RSV)
Document Type:

Still Image
Name as Subject:

ACIP meeting: 2022 Jun 22-23 ; Nirsevimab ; ACIP meeting: 2022 Jun 22-23 ; Nirsevimab
Genre:

Presentation ; Conference Publications
Volume:

202211
Issue:

111103
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

urn:sha-512:3b0ccfc96ca52aefecd2d48db9f5d927d8e900954274214366667314fab019282995560dba4153cea1cdb02c93883f32a122ee489b49f1d897a1d9653530e566
Download URL:

https://stacks.cdc.gov/view/cdc/122373/cdc_122373_DS1.pdf
File Type:

[PDF - 700.28 KB ]

File Language:

English

ON THIS PAGE

Details Related Documents

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.